![]() A common cause of cyanide exposure occurs through smoke inhalation, and quick response is critical. We are glad to be a part of the evolving field of emergency medical care."Ĭyanokit's mechanism of action makes possible the rapid initiation of treatment of cyanide poisoning in both pre-hospital and hospital settings. ![]() Cyanokit also provides a new treatment resource for intentional release of cyanide, an identified potential chemical agent of opportunity for terrorism. and Merck KGaA believe that Cyanokit will have a noticeable and substantial effect on survival of people affected by cyanide poisoning from smoke inhalation and other sources, especially since Cyanokit can be used in both pre-hospital and hospital settings. ![]() "The availability of Cyanokit marks an important step forward for emergency medicine," said Christy Taylor, Executive Vice President of Sales, Marketing and Business Development, Dey, L.P. Cyanokit was approved by the United States Food and Drug administration in December 2006 for the treatment of known or suspected cyanide poisoning. Affiliate of Merck KGaA of Darmstadt, Germany, today announced that Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE is now commercially available in the United States.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |